ASX - By Stock
|
NUZ Biotech |
Re:
Walk to Defeat MND
|
|
adreamer
|
40 |
13K |
23 |
08/09/24 |
08/09/24 |
ASX - By Stock
|
40
|
13K
|
23
|
|
ASX - By Stock
|
NUZ Biotech |
Re:
Walk to Defeat MND
|
|
adreamer
|
40 |
13K |
11 |
06/09/24 |
06/09/24 |
ASX - By Stock
|
40
|
13K
|
11
|
|
ASX - By Stock
|
NUZ Biotech |
Re:
Walk to Defeat MND
|
|
adreamer
|
40 |
13K |
10 |
06/09/24 |
06/09/24 |
ASX - By Stock
|
40
|
13K
|
10
|
|
ASX - By Stock
|
NUZ Biotech |
Re:
Walk to Defeat MND
|
|
adreamer
|
40 |
13K |
6 |
05/09/24 |
05/09/24 |
ASX - By Stock
|
40
|
13K
|
6
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
adreamer
|
97 |
30K |
21 |
05/09/24 |
05/09/24 |
ASX - By Stock
|
97
|
30K
|
21
|
|
ASX - By Stock
|
NUZ Biotech |
Re:
Walk to Defeat MND
|
|
adreamer
|
40 |
13K |
9 |
05/09/24 |
05/09/24 |
ASX - By Stock
|
40
|
13K
|
9
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: Proposed issue of securities - PAA
|
|
adreamer
|
7 |
2.2K |
13 |
05/09/24 |
05/09/24 |
ASX - By Stock
|
7
|
2.2K
|
13
|
|
ASX - By Stock
|
NUZ Biotech |
Re:
Walk to Defeat MND
|
|
adreamer
|
40 |
13K |
12 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
40
|
13K
|
12
|
|
ASX - By Stock
|
NUZ |
Re:
PAA TOP HOLDERS MOVEMENTS AS AT 30 APRIL 2024
|
|
adreamer
|
20 |
8.4K |
0 |
04/08/24 |
04/08/24 |
ASX - By Stock
|
20
|
8.4K
|
0
|
|
ASX - By Stock
|
NUZ |
Re:
Pharmaust - Media & News
|
|
adreamer
|
243 |
84K |
32 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
243
|
84K
|
32
|
|
ASX - By Stock
|
NUZ Algorithmic Trading |
Re:
Stop the rort
|
|
adreamer
|
2 |
1.7K |
19 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
2
|
1.7K
|
19
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: PharmAust Completes Share Purchase Plan
|
|
adreamer
|
107 |
28K |
46 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
107
|
28K
|
46
|
|
ASX - By Stock
|
NUZ Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
adreamer
|
978 |
277K |
19 |
20/07/24 |
20/07/24 |
ASX - By Stock
|
978
|
277K
|
19
|
|
ASX - By Stock
|
NUZ Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
adreamer
|
978 |
277K |
9 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
978
|
277K
|
9
|
|
ASX - By Stock
|
NUZ Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
adreamer
|
978 |
277K |
17 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
978
|
277K
|
17
|
|
ASX - By Stock
|
NUZ Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
adreamer
|
978 |
277K |
35 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
978
|
277K
|
35
|
|
ASX - By Stock
|
NUZ Biotech |
Company Analysis - Morgans
|
|
adreamer
|
19 |
8.6K |
54 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
19
|
8.6K
|
54
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: Trading Halt
|
|
adreamer
|
159 |
42K |
8 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
159
|
42K
|
8
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: Trading Halt
|
|
adreamer
|
159 |
42K |
5 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
159
|
42K
|
5
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: Trading Halt
|
|
adreamer
|
159 |
42K |
2 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
159
|
42K
|
2
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: Trading Halt
|
|
adreamer
|
159 |
42K |
4 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
159
|
42K
|
4
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: Trading Halt
|
|
adreamer
|
159 |
42K |
6 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
159
|
42K
|
6
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: Trading Halt
|
|
adreamer
|
159 |
42K |
7 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
159
|
42K
|
7
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: Trading Halt
|
|
adreamer
|
159 |
42K |
5 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
159
|
42K
|
5
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: Trading Halt
|
|
adreamer
|
159 |
42K |
7 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
159
|
42K
|
7
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: Trading Halt
|
|
adreamer
|
159 |
42K |
11 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
159
|
42K
|
11
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: Trading Halt
|
|
adreamer
|
159 |
42K |
23 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
159
|
42K
|
23
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: Trading Halt
|
|
adreamer
|
159 |
42K |
13 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
159
|
42K
|
13
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: Trading Halt
|
|
adreamer
|
159 |
42K |
5 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
159
|
42K
|
5
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: Trading Halt
|
|
adreamer
|
159 |
42K |
9 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
159
|
42K
|
9
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: Trading Halt
|
|
adreamer
|
159 |
42K |
14 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
159
|
42K
|
14
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: Trading Halt
|
|
adreamer
|
159 |
42K |
9 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
159
|
42K
|
9
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: Trading Halt
|
|
adreamer
|
159 |
42K |
9 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
159
|
42K
|
9
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: Trading Halt
|
|
adreamer
|
159 |
42K |
23 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
159
|
42K
|
23
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: Trading Halt
|
|
adreamer
|
159 |
42K |
23 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
159
|
42K
|
23
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: Trading Halt
|
|
adreamer
|
159 |
42K |
11 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
159
|
42K
|
11
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: Appointment of Non-Executive Director
|
|
adreamer
|
45 |
12K |
34 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
45
|
12K
|
34
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: Appointment of Non-Executive Director
|
|
adreamer
|
45 |
12K |
27 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
45
|
12K
|
27
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: Appointment of Non-Executive Director
|
|
adreamer
|
45 |
12K |
21 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
45
|
12K
|
21
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: Appointment of Non-Executive Director
|
|
adreamer
|
45 |
12K |
36 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
45
|
12K
|
36
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: Appointment of Non-Executive Director
|
|
adreamer
|
45 |
12K |
28 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
45
|
12K
|
28
|
|
ASX - By Stock
|
NUZ |
Re:
Pharmaust - Media & News
|
|
adreamer
|
243 |
84K |
40 |
16/06/24 |
16/06/24 |
ASX - By Stock
|
243
|
84K
|
40
|
|
ASX - By Stock
|
NUZ |
Re:
Pharmaust - Media & News
|
|
adreamer
|
243 |
84K |
7 |
16/06/24 |
16/06/24 |
ASX - By Stock
|
243
|
84K
|
7
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: OLE Study update reveals impressive Survival Data
|
|
adreamer
|
248 |
71K |
12 |
15/06/24 |
15/06/24 |
ASX - By Stock
|
248
|
71K
|
12
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: OLE Study update reveals impressive Survival Data
|
|
adreamer
|
248 |
71K |
9 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
248
|
71K
|
9
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: OLE Study update reveals impressive Survival Data
|
|
adreamer
|
248 |
71K |
9 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
248
|
71K
|
9
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: OLE Study update reveals impressive Survival Data
|
|
adreamer
|
248 |
71K |
21 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
248
|
71K
|
21
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: OLE Study update reveals impressive Survival Data
|
|
adreamer
|
248 |
71K |
18 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
248
|
71K
|
18
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: OLE Study update reveals impressive Survival Data
|
|
adreamer
|
248 |
71K |
4 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
248
|
71K
|
4
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: OLE Study update reveals impressive Survival Data
|
|
adreamer
|
248 |
71K |
9 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
248
|
71K
|
9
|
|